*ST雪萊(002076.SZ):控股股東2624.581萬股質押股票可能被違約處置
格隆匯11月9日丨*ST雪萊(002076.SZ)公佈,公司收到公司控股股東柴國生髮來的《部分質押股票可能被違約處置的提示通知》,因柴國生辦理的股票質押式回購交易違約,其所持雪萊特股份可能被萬和證券實施違約處置,屬於被動減持。根據萬和證券向柴國生髮出的通知,萬和證券將在30個交易日內強制賣出2624.581萬股。
柴國生系公司控股股東,截止2020年11月6日,柴國生持有公司股份1.66億股,佔公司總股本的21.68%。其中,累計被質押的股份1.03億股,佔公司總股本的13.49%;累計被司法凍結的股份1.66億股,佔公司總股本的21.68%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.